Description Baihui (GV20), Yingtang (EX-HN-3), Zusanli (ST36) and Neiguan (PC6)
Experimental Description
Sixty patients undergoing gynecological laparoscopic surgery were randomly assigned to TEAS (TEAS group) or control group (Con group).
Sample Count
60
Control
Sham
control group(n=30)
Experiment
TEAS group(n=30)
Indicator
QoR-40Visual analog scale(VAS)Mini-mental state examination(MMSE)Postoperative Nausea and Vomiting(PONV)Postoperative pain medicationsAntiemetic dosage
Auxiliary Medication
Anesthesia was induced intravenously (i.v.) with propofol and remifentanil using a target-controlled infusion (TCI) system. After loss of consciousness, vecuronium (0.1 mg·kg− 1) was administered i.v., and patients were orotracheally intubated 5 min later.
Stimulation Method
TEAS
Induction Method
Electroacupuncture Instrument Model
Manufacturer
Frequency
Waveform
Strength
Induction Time
Hwato SDZ-V
Hwato,Suzhou Medical Appliances Co., Ltd., Suzhou, China
2/100 Hz
dense-disperse frequency
12-15 mA
30 min
Acupuncture_Needle
Needle_Manufacturer
Needle_Depth
-
-
-
Description The acupoints were then stimulated electrically with an intensity of 12–15 mA and dense-disperse frequency of 2/100 Hz for 30 min, using the Hwato electronic acupuncture treatment instrument (model SDZ-V, Suzhou Medical Appliances Co., Ltd., Suzhou, China). The intensity was adjusted to maintain slight twitching of local muscles according to individual maximum tolerance, indicating a satisfactory De-Qi phenomenon and thus adequate stimulation.
Anesthesia Method
AAA
Clinical Trial Type
random
Contraindications
Neural damage or infection along the meridian at which the acupoints lay
Effector
QoR-40 and MMSE scores of T0 showed no difference between two groups (QoR-40: 197.50 ± 2.57 vs. 195.83 ± 5.17), (MMSE: 26.83 ± 2.74 vs. 27.53 ± 2.88). Compared with the Con group, QoR-40 and MMSE scores of T1 and T2 were higher in the TEAS group (P < 0.05) (QoR-40: T1, 166.07 ± 8.44 vs. 175.33 ± 9.66; T2, 187.73 ± 5.47 vs. 191.40 ±5.74), (MMSE: T1, 24.60 ± 2.35 vs. 26.10 ± 2.78; T2, 26.53 ± 2.94 vs. 27.83 ± 2.73). VAS scores of T1 and T2 were lower (P < 0.05) in the TEAS group (T1, 4.73 ± 1.53 vs. 3.70 ± 1.41; T2, 2.30 ± 0.95 vs. 1.83 ± 0.88); the incidence of postoperative nausea and vomiting (PONV), remedial antiemetics and remedial analgesia was lower in the TEAS group (P < 0.05) (PONV: 56.7% vs. 23.3%; incidence of remedial antiemetics: 53.3% vs. 23.3%; incidence of remedial analgesia: 80% vs. 43.3%).
"The effect of TEAS on the quality of early recovery in patients undergoing gynecological laparoscopic surgery: a prospective, randomized, placebo-controlled trial."
Abstract
INTRODUCTION: In current study we assessed the effect of transcutaneous electrical acupoint stimulation (TEAS) on the quality of early recovery in patients undergoing gynecological laparoscopic surgery. METHODS: Sixty patients undergoing gynecological laparoscopic surgery were randomly assigned to TEAS (TEAS group) or control group (Con group). TEAS consisted of 30 min of stimulation (12-15 mA, 2/100 Hz) at the acupoints of Baihui (GV20), Yingtang (EX-HN-3), Zusanli (ST36) and Neiguan (PC6) before anesthesia. The patients in the Con group had the electrodes applied, but received no stimulation. Quality of recovery was assessed using a 40-item questionnaire as a measure of quality of recovery (QoR-40; maximum score 200) scoring system performed on preoperative day 1 (T0), postoperative day 1 (T1) and postoperative day 2 (T2); 100-mm visual analogue scale (VAS) scores at rest, mini-mental state examination (MMSE) scores, the incidence of nausea and vomiting, postoperative pain medications, and antiemetics were also recorded. RESULTS: QoR-40 and MMSE scores of T0 showed no difference between two groups (QoR-40: 197.50 +/- 2.57 vs. 195.83 +/- 5.17), (MMSE: 26.83 +/- 2.74 vs. 27.53 +/- 2.88). Compared with the Con group, QoR-40 and MMSE scores of T1 and T2 were higher in the TEAS group (P < 0.05) (QoR-40: T1, 166.07 +/- 8.44 vs. 175.33 +/- 9.66; T2, 187.73 +/- 5.47 vs. 191.40 +/- 5.74), (MMSE: T1, 24.60 +/- 2.35 vs. 26.10 +/- 2.78; T2, 26.53 +/- 2.94 vs. 27.83 +/- 2.73). VAS scores of T1 and T2 were lower (P < 0.05) in the TEAS group (T1, 4.73 +/- 1.53 vs. 3.70 +/- 1.41; T2, 2.30 +/- 0.95 vs. 1.83 +/- 0.88); the incidence of postoperative nausea and vomiting (PONV), remedial antiemetics and remedial analgesia was lower in the TEAS group (P < 0.05) (PONV: 56.7% vs. 23.3%; incidence of remedial antiemetics: 53.3% vs. 23.3%; incidence of remedial analgesia: 80% vs. 43.3%). CONCLUSION: The use of TEAS significantly promoted the quality of early recovery, improved MMSE scores and reduced the incidence of pain, nausea and vomiting in patients undergoing gynecological laparoscopic surgery. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02619578. Registered on 2 December 2015. Trial registry name: https://clinicaltrials.gov."
Souce
Trials. 2020 Jan 8;21(1):43. doi: 10.1186/s13063-019-3892-4.
